logo

For the Inventor, By the Inventor

New York, NY, United States of America

Delcath Systems, Inc.


USPTO Granted Patents = 19


Trademarks = 7

Forward Citations = 698

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal William M Appling (12 out of 68 patents)

silverMedal Daniel Stephen Johnston (9 out of 11 patents)

bronzeMedal Jacques Chammas (7 out of 18 patents)

4.  Samantha J Barton (7 out of 7 patents)

5.  Matthew G Barton (5 out of 5 patents)

6.  Stephen N Engelhard (4 out of 4 patents)

7.  Morton G Glickman (4 out of 6 patents)

8.  Eamonn P Hobbs (2 out of 24 patents)

9.  William L Bodden (1 out of 2 patents)


19 patents:

1. 12364797 - Apparatus for removing chemotherapy compounds from blood (2025-07-22),
2. 11867686 - Method of selecting chemotherapeutic agents for an isolated organ or regional therapy (2024-01-09),
3. 11833286 - Filter and frame apparatus and method of use (2023-12-05),
4. 11633528 - Apparatus for removing chemotherapy compounds from blood (2023-04-25),
5. 11241522 - Apparatus for removing chemotherapy compounds from blood (2022-02-08),
6. 11083831 - Filter and frame apparatus and method of use (2021-08-10),
7. 10569004 - Apparatus for removing chemotherapy compounds from blood (2020-02-25),
8. 10369264 - Apparatus for removing chemotherapy compounds from blood (2019-08-06),
9. 10195334 - Filter and frame apparatus and method of use (2019-02-05),
10. 10098997 - Apparatus for removing chemotherapy compounds from blood (2018-10-16),
11. 9707331 - Apparatus for removing chemotherapy compounds from blood (2017-07-18),
12. 9541544 - Method of selecting chemotherapeutic agents for an isolated organ or regional therapy (2017-01-10),
13. 9314561 - Filter and frame apparatus and method of use (2016-04-19),
14. D708749 - Dual filter (2014-07-08),
15. 5919163 - Catheter with slidable balloon (1999-07-06),
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. They develop a unique system for the delivery of high-dose chemotherapy directly to the liver, known as the Delcath Hepatic Delivery System. This targeted therapy aims to improve treatment outcomes for patients with liver metastases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Delcath Systems, Inc.
19 Patents

#419 in New York, NY

#1,004 in New York

#17,104 in US

#32,571 in the World

New York, NY (US)
New York, NY, United States of America

Delcath Systems, Inc.

Forward Citations = 698

9 inventors:

goldMedal William M Appling (12 out of 68 patents)

silverMedal Daniel Stephen Johnston (9 out of 11 patents)

bronzeMedal Jacques Chammas (7 out of 18 patents)

4.  Samantha J Barton (7 out of 7 patents)

5.  Matthew G Barton (5 out of 5 patents)

Please report any incorrect information to [email protected]
Loading…